{"disease":{"id":"biopsy-proven-histologic-scores","name":"biopsy proven histologic scores"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06744647","title":"Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}